Bilcare Ltd
BSE:526853
Bilcare Ltd
BSE:526853
Price:
61.45 INR
-1.92%
Market Closed
Updated:
May 17, 2024
Bilcare Ltd
Cost of Revenue
|
Bilcare Ltd
Cost of Revenue Peer Comparison
Comparables:
DIVISLAB
DCAL
SYNGENE
TARSONS
I
INNOVACAP
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bilcare Ltd
BSE:526853
|
Cost of Revenue
-₹5.3B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
20%
|
CAGR 10-Years
11%
|
|
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
Cost of Revenue
-₹36.9B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Dishman Carbogen Amcis Ltd
NSE:DCAL
|
Cost of Revenue
-₹6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Syngene International Ltd
NSE:SYNGENE
|
Cost of Revenue
-₹9.3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Tarsons Products Ltd
NSE:TARSONS
|
Cost of Revenue
-₹942.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I
|
Innova Captab Ltd
NSE:INNOVACAP
|
Cost of Revenue
-₹7.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bilcare Ltd's Cost of Revenue?
Cost of Revenue
-5.3B
INR
-5.3B
INR
Based on the financial report for Dec 31, 2023, Bilcare Ltd's Cost of Revenue amounts to -5.3B INR.
What is Bilcare Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
11%
11%
Over the last year, the Cost of Revenue growth was 28%. The average annual Cost of Revenue growth rates for Bilcare Ltd have been -13% over the past three years , 20% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet
